Contact
Please use this form to send email to PR contact of this press release:
APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia
TO:
Please use this form to send email to PR contact of this press release:
APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia
TO: